Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Abstract
Increasing evidence demonstrates that neuroplasticity, a fundamental mechanism of neuronal adaptation, is disrupted in mood disorders and in animal models of stress. Here we provide an overview of the evidence that chronic stress, which can precipitate or exacerbate depression, disrupts neuroplasticity, while antidepressant treatment produces opposing effects and can enhance neuroplasticity. We discuss neuroplasticity at different levels: structural plasticity (such as plastic changes in spine and dendrite morphology as well as adult neurogenesis), functional synaptic plasticity, and the molecular and cellular mechanisms accompanying such changes. Together, these studies elucidate mechanisms that may contribute to the pathophysiology of depression. Greater appreciation of the convergence of mechanisms between stress, depression, and neuroplasticity is likely to lead to the identification of novel targets for more efficacious treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“current evidence indicates that impairment in growth factor signaling is associated with depressed mood (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“neurotrophic growth factors and related signaling pathways constitute major players in neuroplasticity”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“In addition, clean-cut evidence shows that antidepressants require neuroplasticity pathways to rescue the observed deficits in neuronal and synaptic plasticity often associated with mood disorders (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“While traditional antidepressants acutely increase synaptic levels of monoamines, their chronic administration leads to changes in structural neuroplasticity that are contemporaneous with their clinical therapeutic effects (10–12).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
In the citing paper
“these changes in neural circuitry are believed to underlie the deficits in learning/memory, mood, motivation, and reward seeking that are characteristic of depression and related disorders (10, 67–74)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Items 201–257 of 257
Diagnosis and management of patients with bipolar II disorder.
Yatham, L. N. (2005) · PubMed · Cited by 163
Chambers, R. A., Potenza, M. N., Hoffman, R. E., & Miranker, W. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300358 · Cited by 162 · cited 1×
“Some computational theories of hippocampal function predict a role for new neurons in hippocampus-dependent learning (Chambers et al, 2004).”
BackgroundThe Role of the Extracellular Signal-regulated Kinase Pathway in Memory Encoding
Giovannini, M. G. (2006) · Reviews in the Neurosciences · doi:10.1515/revneuro.2006.17.6.619 · Cited by 154 · cited 1×
“This cascade of kinases is critical for the induction of long-lasting synaptic plasticity in the hippocampus , amygdala, and cortex (Atkins et al, 1998; Huang et al, 2000; Di Cristo et al, 2001; reviewed in Giovannini, 2006).”
BackgroundFranklin, T. B., & Perrot-Sinal, T. S. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.05.008 · Cited by 148 · cited 1×
“Both acute and chronic stress lead to reductions in hippocampal BDNF mRNA levels, suggesting an impairment of some of the mechanisms of neuroplasticity (Nibuya et al, 1995, 1999; Smith et al, 1995; Russo-Neustadt et al, 2001; Rasmusson et al, 2002; Franklin and Perrot-Sinal, 2006).”
BackgroundMowla, A., Mosavinasab, M., & Pani, A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802e0002 · Cited by 141 · cited 1×
“One recent double-blind study suggested improvement in memory and a variety of other cognitive domains with chronic fluoxetine treatment in elderly patients with mild cognitive impairment (Mowla et al, 2007).”
BackgroundMetabotropic Glutamate Receptors in the Control of Mood Disorders
Witkin, J., Marek, G., Johnson, B., & Schoepp, D. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363302 · Cited by 140
Yamada, S., Yamamoto, M., Ozawa, H., Riederer, P. F., & Saito, T. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0810-8 · Cited by 139
Brain-Derived Neurotrophic Factor in Amygdala-Dependent Learning
Rattiner, L. M., Davis, M., & Ressler, K. J. (2005) · The Neuroscientist · doi:10.1177/1073858404272255 · Cited by 139 · cited 1×
“Once again, this has been demonstrated in hippocampus (Patterson et al, 1996), amygdala (Rattiner et al, 2005), and cortex (Bartoletti et al, 2002).”
BackgroundZschocke, J., Bayatti, N., Clement, A. M., Witan, H., Figiel, M., Engele, J., & Behl, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502581200 · Cited by 137 · cited 1×
“Exposure to glucocorticoids increases expression of the primary glial glutamate transporter, GLT-1 (Zschocke et al, 2005; Autry et al, 2006); this may serve to increase reuptake of elevated extracellular glutamate in conditions of chronic stress.”
BackgroundDwivedi, Y., Rizavi, H. S., Conley, R. R., & Pandey, G. N. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001744 · Cited by 135
Lateral amygdaloid nucleus expansion in adult rats is associated with exposure to prenatal stress
Salm, A. K., Pavelko, M., Krouse, E. M., Webster, W., Kraszpulski, M., & Birkle, D. L. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2003.11.005 · Cited by 125
Pickering, C., Gustafsson, L., Cebere, A., Nylander, I., & Liljequist, S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.136 · Cited by 124 · cited 2×
“…has been shown to lead to lasting reduction in the expression of the NMDA receptor subunit NR2B and of the AMPA receptor subunits GluR1 and GluR2 (Pickering et al, 2006); differences in the level and chronicity of stress or glucocorticoid exposure may explain these contrasting results, which…”
ResultMemory impairment in patients with late-onset major depression: The effect of antidepressant therapy
Gallassi, R., Di Sarro, R., Morreale, A., & Amore, M. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.01.018 · Cited by 118 · cited 1×
“…recent study found improvements in verbal memory after treatment of depressed patients with fluoxetine (Vythilingam et al, 2004); another found improvements in memory and attention in patients with late-onset depression after treatment with either fluoxetine or reboxetine (Gallassi et al, 2006).”
BackgroundAlonso, G. (2000) · Glia · doi:10.1002/1098-1136(200009)31:3<219::aid-glia30>3.0.co;2-r · Cited by 115 · cited 1×
“In animals, chronic unpredictable stress results in a reduction in the proliferation of glia and endothelial cells in the mPFC (Banasr et al, 2007); exposure to glucocorticoids causes a similar effect (Alonso, 2000).”
BackgroundAMPA Receptors in the Therapeutic Management of Depression
Bleakman, D., Alt, A., & Witkin, J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363258 · Cited by 114
Fumagalli, F., Molteni, R., Calabrese, F., Frasca, A., Racagni, G., & Riva, M. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03149.x · Cited by 111
Long-Term Effects of Brief Acute Stress on Cellular Signaling and Hippocampal LTP
Ahmed, T., Frey, J. U., & Korz, V. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4901-05.2006 · Cited by 111 · cited 6×
“For example, the calcium-calmodulin-dependent kinase II (CaMKII), which is activated by local increases in calcium, is critical for early LTP. CaMKII has unique properties that make it well suited to a role in the induction of synaptic plasticity.”
BackgroundInfluentialMemory and ECT: From Polarization to Reconciliation
Sackeïm, H. A. (2000) · Journal of Ect · doi:10.1097/00124509-200006000-00001 · Cited by 108 · cited 1×
“Examination of cognitive improvement in patients receiving ECT is complicated by the fact that memory difficulties, especially retrograde amnesia, are a clear side effect of the treatment (Sackeim, 2000).”
BackgroundYau, J. L. W., Noble, J., Hibberd, C., Rowe, W. B., Meaney, M. J., Morris, R. G. M., & Seckl, J. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01436.2002 · Cited by 106 · cited 1×
“Chronic imipramine or tianeptine were not effective in the Morris water maze (Nowakowska et al, 2000, 2003), although another study found that chronic amitriptyline prevents age-induced impairments in learning and memory (Yau et al, 2002).”
BackgroundPerez, J., Tinelli, D., Brunello, N., & Racagni, G. (1989) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(89)90060-6 · Cited by 105
Pittenger, C., Fasano, S., Mazzocchi-Jones, D., Dunnett, S. B., Kandel, E. R., & Brambilla, R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5406-05.2006 · Cited by 104 · cited 1×
“…synaptic stimulation and after learning in the hippocampus, amygdala, and cortex; and CREB inhibition in these and other brain regions disrupts LTP and corresponding forms of longlasting memory (Glazewski et al, 1999; Pittenger et al, 2002, 2006; Kida et al, 2002; reviewed in Carlezon et al, 2005).”
BackgroundSelf-citationG protein signaling and the molecular basis of antidepressant action
Donati, R. J., & Rasenick, M. M. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00249-2 · Cited by 102
Sequence variations in CREB1 cosegregate with depressive disorders in women
Zubenko, G. S., Hughes, H. B., Stiffler, J. S., Brechbiel, A., Zubenko, W. N., Maher, B. S., & Marazita, M. L. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001354 · Cited by 102
Vouimba, R.-M., Muñoz, C., & Diamond, D. M. (2006) · Stress · doi:10.1080/10253890600610973 · Cited by 96 · cited 7×
“…antidepressant medications with less anticholinergic effect, have suggested that chronic administration of an SSRI or an atypical antidepressant (tianeptine) increases LTP and blocks the stress-induced impairment of LTP and enhancement of LTD in CA1 (Vouimba et al, 2006; Holderbach et al, 2007).”
BackgroundInfluentialBartoletti, A., Cancedda, L., Reid, S. W., Tessarollo, L., Porciatti, V., Pizzorusso, T., & Maffei, L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10072.2002 · Cited by 96 · cited 1×
“Once again, this has been demonstrated in hippocampus (Patterson et al, 1996), amygdala (Rattiner et al, 2005), and cortex (Bartoletti et al, 2002).”
BackgroundEffects of major depression on estimates of intelligence
Sackeim, H. A., Freeman, J., McElhiney, M., Coleman, E., Prudic, J., & Devanand, D. P. (1992) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639208402828 · Cited by 90 · cited 1×
“However, many patients show clear cognitive improvement, even shortly after treatment (Sackeim et al, 1992).”
BackgroundMaroun, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05169.x · Cited by 82 · cited 1×
“At the reverse projection, from PFC to amygdala, stress shifts the balance from one that favors LTD to one that favors LTP (Maroun, 2006).”
BackgroundChanges in CREB-phosphorylation during recovery from major depression
Koch, J. M., Kell, S., Hinze‐Selch, D., & Aldenhoff, J. B. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00056-0 · Cited by 79
Frechilla, D., Otano, A., & Río, J. D. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00040-2 · Cited by 79
Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline
Allain, H., Lieury, A., Brunet-Bourgin, F., Mirabaud, C., Trébon, P., Coz, F. L., & Gandon, J. M. (1992) · Psychopharmacology · doi:10.1007/bf02246237 · Cited by 74 · cited 1×
“An early study found improvement in memory with treatment with the monoamine oxidase inhibitor (MAOI) moclobemide, which was superior to that of the adrenergic agonist viloxazine or the tetracyclic antidepressant maprotiline (Allain et al, 1992).”
BackgroundRegulation of Neurogenesis and Angiogenesis in Depression
Newton, S., & Duman, R. (2004) · Current Neurovascular Research · doi:10.2174/1567202043362388 · Cited by 72 · cited 1×
“The involvement of trophic factors beyond BDNF suggests that a multifaceted machinery of neuronal support may be impaired by stress and, possibly, enhanced by antidepressant therapies (Newton and Duman, 2004).”
BackgroundSelf-citationvon Frijtag, J. C., Kamal, A., Reijmers, L. G. J. E., Schrama, L. H., van den Bos, R., & Spruijt, B. M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02062-6 · Cited by 72 · cited 1×
“In contrast, most early studies of CA1 pyramidal cells report that chronic antidepressant treatment decreases LTP (Massicotte et al, 1993; O'Connor et al, 1993; Von Frijtag et al, 2001).”
ResultOdagaki, Y., García-Sevilla, J. A., Huguelet, P., Harpe, R. L., Koyama, T., & Guimón, J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02188-6 · Cited by 70
Levkovitz, Y., Grisaru, N., & Segal, M. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00244-x · Cited by 69 · cited 2×
“In the dentate gyrus, where high-frequency stimulation of the perforant pathway projection to granule cells is used to stimulate LTP, both chronic ECS and chemical antidepressant treatment increase LTP (Stewart and Reid, 2000; Levkovitz et al, 2001).”
BackgroundGlazewski, S. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.3.249 · Cited by 68
Pardon, M., Roberts, R. E., Marsden, C. A., Bianchi, M., Latif, M. L., Duxon, M. S., & Kendall, D. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.033 · Cited by 64
Perez, J., Tardito, D., Mori, S., Racagni, G., Smeraldi, E., & Zanardi, R. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020104.x · Cited by 62
Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole
Albo, F., Pieri, M., & Zona, C. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20244 · Cited by 61
Gould, E., & Cameron, H. A. (1997) · Behavioral Neuroscience · doi:10.1037//0735-7044.111.1.49 · Cited by 61 · cited 1×
“This possibility is supported by the observation that NMDA receptor antagonists increase the expression of BDNF, and activity-dependent gene expression (Metsis et al, 1993), and increase adult hippocampal neurogenesis (Gould and Cameron, 1997).”
BackgroundPopoli, M., Vocaturo, C., Perez, J., Smeraldi, E., & Racagni, G. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10514-2 · Cited by 59
Jaffard, R., Mocaer, E., Poignant, J.-C., Micheau, J., Marighetto, A., Meunier, M., & B??racoch??a, D. (1991) · Behavioural Pharmacology · doi:10.1097/00008877-199102000-00006 · Cited by 56 · cited 1×
“Tianeptine, but not fluoxetine, has been reported to improve discrimination performance in a radial maze task (Jaffard et al, 1991).”
BackgroundBarbiero, V. S., Giambelli, R., Musazzi, L., Tiraboschi, E., Tardito, D., Pérez, J., Drago, F., Racagni, G., & Popoli, M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301378 · Cited by 53
Naudon, L., Hotte, M., & Jay, T. M. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0660-4 · Cited by 49 · cited 1×
“Finally, chronic imipramine, but not paroxetine, has recently been reported to impair spatial working memory in a radial arm maze task (Naudon et al, 2007).”
BackgroundGlucocorticoid Regulation of GLT-1 Glutamate Transporter Isoform Expression in the Rat Hippocampus
Autry, A. E., Grillo, C. A., Piroli, G. G., Rothstein, J. D., McEwen, B. S., & Reagan, L. P. (2006) · Neuroendocrinology · doi:10.1159/000096092 · Cited by 48 · cited 1×
“Exposure to glucocorticoids increases expression of the primary glial glutamate transporter, GLT-1 (Zschocke et al, 2005; Autry et al, 2006); this may serve to increase reuptake of elevated extracellular glutamate in conditions of chronic stress.”
BackgroundPerlis, R. H., Purcell, S., Fagerness, J. A., Cusin, C., Yamaki, L. H., Fava, M., & Smoller, J. W. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.034 · Cited by 45
Alfonso, J., Agüero, F., Sánchez, D. O., Flügge, G., Fuchs, E., Frasch, A. C. C., & Pollevick, G. D. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20328 · Cited by 45 · cited 1×
“Recently, gene profiling of animals exposed to stress has identified other genes that are differentially regulated by stress or glucocorticoids (Alfonso et al, 2004); many genes so identified have roles in neuroplasticity.”
BackgroundCelano, E., Tiraboschi, E., Consogno, E., D’Urso, G., Mbakop, M. P., Gennarelli, M., de Bartolomeis, A., Racagni, G., & Popoli, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01491-9 · Cited by 43
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation
Tiraboschi, E., Giambelli, R., DʼUrso, G., Galietta, A., Barbon, A., de Bartolomeis, A., Gennarelli, M., Barlati, S., Racagni, G., & Popoli, M. (2004) · NeuroReport · doi:10.1097/00001756-200410250-00018 · Cited by 41
Nowakowska, E., Kus, K., Chodera, A., & Rybakowski, J. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300156 · Cited by 41 · cited 2×
“…or venlafaxine, a mixed action reuptake inhibitor, is reported to improve performance in the Morris water maze, a spatial learning and memory model (Nowakowska et al, 2000, 2003, 2006), although another study found that fluoxetine did not influence performance in this task (Stewart and Reid, 2000).”
BackgroundResultFumagalli, F., Frasca, A., Spartà, M., Drago, F., Racagni, G., & Riva, M. A. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019828 · Cited by 34
Chronic glucocorticoid receptor activation impairs CREB transcriptional activity in clonal neurons
Föcking, M., Hölker, I., & Trapp, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00665-x · Cited by 32
Chronic effects of trimipramine, an antidepressant, on hippocampal synaptic plasticity
Massicotte, G., Bernard, J., & Ohayon, M. M. (1993) · Behavioral and Neural Biology · doi:10.1016/0163-1047(93)90808-u · Cited by 31 · cited 1×
“In contrast, most early studies of CA1 pyramidal cells report that chronic antidepressant treatment decreases LTP (Massicotte et al, 1993; O'Connor et al, 1993; Von Frijtag et al, 2001).”
ResultNowakowska, E., Kus, K., Florek, E., Czubak, A., & Jodynis-Liebert, J. (2006) · Human & Experimental Toxicology · doi:10.1191/0960327106ht611oa · Cited by 29 · cited 1×
“…or venlafaxine, a mixed action reuptake inhibitor, is reported to improve performance in the Morris water maze, a spatial learning and memory model (Nowakowska et al, 2000, 2003, 2006), although another study found that fluoxetine did not influence performance in this task (Stewart and Reid, 2000).”
ResultDexamethasone Treatment and ICAM-1 Deficiency Impair VEGF-Induced Angiogenesis in Adult Brain
Kasselman, L. J., Kintner, J., Sideris, A., Pasnikowski, E. M., Krellman, J. W., Shah, S., Rudge, J. S., Yancopoulos, G. D., Wiegand, S. J., & Croll, S. D. (2007) · Journal of Vascular Research · doi:10.1159/000101450 · Cited by 29 · cited 1×
“Similarly, VEGF's angiogenic actions are impaired by glucocorticoid treatment (Kasselman et al, 2007).”
BackgroundAberrant Extracellular Signal-Regulated Kinase (ERK) 5 Signaling in Hippocampus of Suicide Subjects
Dwivedi, Y., Rizavi, H. S., Teppen, T. L., Sasaki, N., Chen, H., Zhang, H., Roberts, R. C., Conley, R. R., & Pandey, G. N. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301372 · Cited by 27
Lee, S., Kang, J. S., Song, G., & Myung, C. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.07.001 · Cited by 22 · cited 1×
“For example, several forms of chronic stress have been observed to increase the phosphorylation of MAPK (Pardon et al, 2005; Lee et al, 2006).”
BackgroundComparison of Behavioural Effects of Venlafaxine and Imipramine in Rats
Nowakowska, E., Kus, K., & Chodera, A. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1297102 · Cited by 21 · cited 2×
“…or venlafaxine, a mixed action reuptake inhibitor, is reported to improve performance in the Morris water maze, a spatial learning and memory model (Nowakowska et al, 2000, 2003, 2006), although another study found that fluoxetine did not influence performance in this task (Stewart and Reid, 2000).”
BackgroundResult
Research works printed but not linked: 3
- American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders (DSM) IV-TR. American Psychiatric Press: Washington, DC.
- Nemeroff CB (2006). Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psych 66 (S8): 13–21.
- O'Connor JJ, Rowan MJ, Anwyl R (1993). Naunyn Schmiedebergs Arch. Pharmacology 348: 158–163.
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
“hippocampus by chronic antidepressant treatment [2,53,68,69].”
McEwen, B. S., & Gianaros, P. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05331.x · Cited by 1,715
Kandola, A., Ashdown-Franks, G., Hendrikse, J., Sabiston, C. M., & Stubbs, B. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.040 · Cited by 1,309
Metadata
- Authors
- Pittenger, C., & Duman, R. S.
- Affiliations
- Yale University (US)
- Corresponding author
- Duman, Ronald S
- Venue
- Neuropsychopharmacology
- Published
- 2007-09-12
- Volume
- 33
- Issue
- 1
- Pages
- 88-109
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1978891587
- Cited by
- 1,795
- References
- 257
- Citations by year
- 2026: 48 · 2025: 77 · 2024: 83 · 2023: 73 · 2022: 98 · 2021: 137 · 2020: 107 · 2019: 95 · 2018: 97 · 2017: 105 · 2016: 97 · 2015: 99 · 2014: 112 · 2013: 108 · 2012: 147
- FWCI
- 6.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- chronic stress, depression, neuroplasticity, antidepressants, structural plasticity, adult neurogenesis, synaptic plasticity, dendritic spine morphology, mood disorders, animal models of stress, depression pathophysiology
- MeSH terms
- Animals, Depression, Humans, Learning Disabilities, Memory Disorders, Models, Neurological, Neuronal Plasticity, Neurons, Stress, Physiological, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.